Effect and mechanism of FGF21 on astrocyte damage induced by Aβ<sub>25-35</sub>

SUN Yan; GAO Xiangdong; CHEN Song

doi:10.11665/j.issn.1000-5048.20190415

Journal of China Pharmaceutical University > 2019 > 50(4): 490-496. > DOI: 10.11665/j.issn.1000-5048.20190415

SUN Yan, GAO Xiangdong, CHEN Song. Effect and mechanism of FGF21 on astrocyte damage induced by Aβ_25-35[J]. Journal of China Pharmaceutical University, 2019, 50(4): 490-496. DOI: 10.11665/j.issn.1000-5048.20190415

Citation:

PDF (3192 KB)

Effect and mechanism of FGF21 on astrocyte damage induced by Aβ_25-35

More Information

Graphical Abstract

Abstract

Abstract

To investigate the effects and mechanism of fibroblast growth factor 21(FGF21)on astrocytes in AD-like lesions, Aβ_25-35 was used to induce astrocyte model damaged. Cell model was established by inducing C6 astrocyte cell line and primary astrocyte damage with Aβ_25-35_.Different concentrations of FGF21 were used to intervene cell injury model induced by Aβ_25-35, and cell viabilities were detected by MTT assay. Effects of FGF21 and Aβ_25-35 on reactive oxygen species(ROS)levels in C6 cells were tested using DCFH-DA probe and flow cytometry. Western blot was used to assess the effects of FGF21 and Aβ_25-35 on the activities of mitogen-activated protein kinases(MAPKs)in C6 cells. The results showed that FGF21 could reduce the damage of C6 cells and primary astrocytes induced by Aβ_25-35, down-regulate the abnormal ROS level in C6 cells, and alleviate the abnormal phosphorylation levels of MEK1/2, ERK1/2 and p38 in C6 cells induced by Aβ_25-35, suggesting that FGF21 may attenuate Aβ_25-35-induced astrocyte damage by regulating ROS pathway and MAPKs signaling pathway.
- fibroblast growth factor 21,
- Alzheimer′s disease,
- astrocytes,
- reactive oxygen species,
- mitogen-activated protein kinases

FullText(HTML)

References (21)

References

[1]	Cheignon C,Tomas M,Bonnefont-Rousselot D,et al.Oxidative stress and the amyloid beta peptide in Alzheimer′s disease[J].Redox Biol,2018,14:450-464.
[2]	Scheltens P,Blennow K,Breteler MMB,et al.Alzheimer′s disease[J].Lancet,2016,388(10043):505-517.
[3]	Jahanshahi M,Sadeghi Y,Hosseini A,et al.The effect of spatial learning on the number of astrocytes in the CA3 subfield of the rat hippocampus[J].Singapore Med J,2008,49(5):388-391.
[4]	Suzuki A,Stern SA,Bozdagi O,et al.Astrocyte-neuron lactate transport is required for long-term memory formation[J].Cell,2011,144(5):810-823.
[5]	Kawano H,Oyabu K,Yamamoto H,et al.Astrocytes with previous chronic exposure to amyloid β-peptide fragment 1-40 suppress excitatory synaptic transmission[J].J Neurochem,2017,143(6):624-634.
[6]	Leszek J,Trypka E,Tarasov VV,et al.Type 3 diabetes mellitus:a novel implication of Alzheimer′s disease[J].Curr Top Med Chem,2017,17(12):1331-1335.
[7]	Giralt M,Gavaldà-Navarro A,Villarroya F.Fibroblast growth factor-21,energy balance and obesity[J].Mol Cell Endocrinol,2015,418(Pt 1):66-73.
[8]	Degirolamo C,Sabbà C,Moschetta A.Therapeutic potential of the endocrine fibroblast growth factors FGF19,FGF21 and FGF23[J].Nat Rev Drug Discov,2016,15(1):51-69.
[9]	Hsuchou H,Pan WH,Kastin AJ.The fasting polypeptide FGF21 can enter brain from blood[J].Peptides,2007,28(12):2382-2386.
[10]	Fon Tacer K,Bookout AL,Ding XS,et al.Research resource:comprehensive expression atlas of the fibroblast growth factor system in adult mouse[J].Mol Endocrinol,2010,24(10):2050-2064.
[11]	Sa-Nguanmoo P,Tanajak P,Kerdphoo S,et al.FGF21 improves cognition by restored synaptic plasticity,dendritic spine density,brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats[J].Horm Behav,2016,85:86-95.
[12]	Chen ST,Chen S,Gao XD.Construction,expression,purification and neuroprotective activity of TAT-FGF21 fusion protein[J].J China Pharm Univ(中国药科大学学报),2018,49(4):496-501.
[13]	Jack CR Jr,Knopman DS,Jagust WJ,et al.Hypothetical model of dynamic biomarkers of the Alzheimer′s pathological cascade[J].Lancet Neurol,2010,9(1):119-128.
[14]	Selkoe DJ.Alzheimer disease:mechanistic understanding predicts novel therapies[J].Ann Intern Med,2004,140(8):627-638.
[15]	Selkoe DJ,Hardy J.The amyloid hypothesis of Alzheimer′s disease at 25 years[J].EMBO Mol Med,2016,8(6):595-608.
[16]	Poprac P,Jomova K,Simunkova M,et al.Targeting free radicals in oxidative stress-related human diseases[J].Trends Pharmacol Sci,2017,38(7):592-607.
[17]	Cheignon C,Tomas M,Bonnefont-Rousselot D,et al.Oxidative stress and the amyloid beta peptide in Alzheimer′s disease[J].Redox Biol,2018,14:450-464.
[18]	Rodríguez-Arellano JJ,Parpura V,Zorec R,et al.Astrocytes in physiological aging and Alzheimer′s disease[J].Neuroscience,2016,323:170-182.
[19]	Wang K,Yao Y,Zhu X,et al.Amyloid β induces NLRP3 inflammasome activation in retinal pigment epithelial cells via NADPH oxidase-and mitochondria-dependent ROS production[J].J Biochem Mol Toxicol,2017,31(6):e21887.
[20]	Xu Z,Chen S,Wang Y,et al.Neuroprotective effects of silk fibroin hydrolysate against Aβ25-35 induced cytotoxicity in SH-SY5Y cells and primary hippocampal neurons by regulating ROS inactivation of PP2A[J].J Funct Foods,2018,45:100-109.
[21]	Kirouac L,Rajic AJ,Cribbs DH,et al.Activation of ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer′s disease[J].eNeuro,2017,4(2).pii:ENEURO.0149-16.2017.

[1]	SHANG Feiyang, LIU Chengbo, TAN Hongzhou, HE Bing, HE Liqin. Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives[J]. Journal of China Pharmaceutical University, 2024, 55(3): 367-374. DOI: 10.11665/j.issn.1000-5048.2023072901
[2]	HU Yuheng, SUN Jie, YANG Jie, WANG Xiaojing. Synthesis and in vitro hypoglycemic activity of 3-(4′-benzoyl amino-phenyl)-coumarin derivatives[J]. Journal of China Pharmaceutical University, 2019, 50(2): 168-174. DOI: 10.11665/j.issn.1000-5048.20190206
[3]	YANG Guoxun, XIONG Juan, HU Jinfeng. 2017′s advanced natural products chemistry researches in China(2)[J]. Journal of China Pharmaceutical University, 2018, 49(6): 637-645. DOI: 10.11665/j.issn.1000-5048.20180601
[4]	YANG Guoxun, XIONG Juan, HU Jinfeng. 2017′s advanced natural products chemistry researches in China(1)[J]. Journal of China Pharmaceutical University, 2018, 49(5): 511-520. DOI: 10.11665/j.issn.1000-5048.20180501
[5]	YANG Rui, ZHU Yi, WANG Yin, MA Wenqi, WANG Xin, HAN Xiqiong, LIU Naifeng. Recent progress in autophagy and vascular calcification[J]. Journal of China Pharmaceutical University, 2018, 49(4): 401-406. DOI: 10.11665/j.issn.1000-5048.20180403
[6]	JIN Yue, WU Xuri, CHEN Yijun. Applications of glycosyltransferases in the improvement of druggability of natural products[J]. Journal of China Pharmaceutical University, 2017, 48(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20170504
[7]	YU Sulan, YU Xiu, KOU Junping. Advances in the mechanism research of natural products against acute lung injury[J]. Journal of China Pharmaceutical University, 2016, 47(4): 397-403. DOI: 10.11665/j.issn.1000-5048.20160403
[8]	XIANG Min, ZHANG Yaqin, WU Pingping, GAO Zhenyu. Effect of block of AGEs-RAGE pathway on the migration of VSMCs[J]. Journal of China Pharmaceutical University, 2016, 47(2): 199-203. DOI: 10.11665/j.issn.1000-5048.20160212
[10]	YANG Ya-Bo, WANG Min, LIANG Yan, LIANG Jing-Yu. Transgalactosylation of Isotaxiresinol by[J]. Journal of China Pharmaceutical University, 2002, (6).

Cited By

Get Citation

PDF

XML

Article views (467) PDF downloads (787)

Turn off MathJax

Article Contents

Abstract

References

Effect and mechanism of FGF21 on astrocyte damage induced by Aβ_25-35

Abstract

References

Related Articles

Catalog

Effect and mechanism of FGF21 on astrocyte damage induced by Aβ25-35

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content

Effect and mechanism of FGF21 on astrocyte damage induced by Aβ_25-35